Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19

Viruses. 2021 May 11;13(5):878. doi: 10.3390/v13050878.

Abstract

Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection.

Keywords: COVID-19-associated coagulopathy; SARS-CoV-2; coagulation disorders; venous thromboembolism.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Blood Coagulation Disorders / complications
  • COVID-19 / complications*
  • COVID-19 / diagnosis*
  • Humans
  • Male
  • Neoplasm Recurrence, Local
  • Polymerase Chain Reaction
  • RNA, Viral
  • Recurrence
  • Risk Factors
  • Upper Extremity / blood supply
  • Venous Thrombosis / complications*
  • Venous Thrombosis / diagnosis*
  • Venous Thrombosis / therapy

Substances

  • RNA, Viral